Of 71 surgically treated patients with myeloma bone disease, evaluated for CRP elevation prior to surgery, 26 (36.6%) were assigned to the negative group and 45 (63.4%) to the positive group. The gene discussed is CRP; the disease is plasma cell myeloma.